A New Generation of Cytokine-Based Immunotherapy Takes Shape

Nearly 40 years after the first cytokine-based therapy was approved for the treatment of patients with hairy cell leukemia, investigators are taking a fresh look at ways to leverage these signaling proteins to enhance immunotherapies and vaccines in other cancers.

Related Keywords

Taghi Khani , Sanchez Ortiz , National Cancer Institute , Cytokine Development , Merck Kga , Therapeutics Inc , Merck Kgaa , Bristol Myers Squibb , Cancer Research Institute , Astrazeneca , Influence Cell Signaling , Select Cytokines Investigated , Interferon Cytokine , Accessed March , Opin Chem , Des Devel , Transduct Target , Accessed February , Cytokine Based Immunotherapy , T Cells , Interleukins , Tumor Necrosis Factors , Chemokines , Interferons ,